N-VIRO INTERNATIONAL CORP
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>doc2.txt
<TEXT>
                                                                    Exhibit 10.1
                                                                    ------------

                                              NEWS RELEASE FOR IMMEDIATE RELEASE
                                                   For More Information Contact:
                                            Phillip Levin, Chairman of the Board
                                                 info@nviro.com   (419) 535-6374

       N-VIRO ANNOUNCES SIGNIFICANT IMPROVEMENT IN 2004 FINANCIAL RESULTS

Toledo,  Ohio,  Monday,  April  4,  2005  -  N-Viro  International  Corp.  (OTC
BB/NVIC.OB) announced the Company's financial results for the fourth quarter and
year  ended  December  31,  2004.

Chairman  Phillip  Levin stated, "N-Viro is very pleased with its 2004 financial
results.  Our  2003  loss was over $1.5 million, but in 2004 it was only $71,000
and,  due  to  depreciation  and  other non-cash expenses, cash basis income was
approximately $500,000.  Fourth quarter 2004 earnings were $14,000 compared to a
$711,000  loss  in  2003."

"Beginning  in  May  of  2004,  our management and consulting team embarked on a
program to reduce operational costs by over $600,000.  Dan Haslinger, who became
CEO  this  past  January,  is  focused  on  continued  cost  reduction  and  the
development  of  additional  revenue  sources.  Our  independent  auditors  have
recognized  these operating improvements, as demonstrated by the removal of last
year's  going  concern  qualification  in  the  auditor's report.  The Company's
balance  sheet  is  greatly improved due to a successful private stock placement
effort,  the  proceeds  of  which  were  used  to reduce debt.  Recently elected
directors  Carl  Richard  and  Joe  Scheib have added valuable experience to our
team.  We are confident the positive trends initiated in 2004 will continue into
the  future,"  commented  Levin.

"N-Viro  also  has retained Quest Equities, LLC as a consultant charged with the
mission  of  enhancing  shareholder  value  in  the  near term.  We are eager to
advance  our  work with Quest and to pursue various initiatives which are on the
drawing  board.  As  Chairman it will be a great pleasure to address the Company
shareholders  at  our upcoming annual meeting in light of our improved financial
report.  Many  of  the changes that have been implemented are only now beginning
to  show  results.  As  our team continues its work our financial condition will
continue  to  improve,"  Levin  concluded.

About  N-Viro
-------------
N-Viro  International  Corporation  develops  and  licenses  its  technology  to
municipalities  and  private  companies.  N-Viro's  patented  processes use lime
and/or  mineral-rich, combustion byproducts to treat, pasteurize, immobilize and
convert  wastewater  sludge  and  other  bio-organic  wastes  into  biomineral
agricultural  and  soil-enrichment  products  with  real  market  value.  More
information  about N-Viro International can be obtained by contacting the office
or  on  the  Internet  at  www.nviro.com or by e-mail inquiry to info@nviro.com.
                           -------------                         --------------

Forward  Looking  Statements
----------------------------
The  Company  cautions  that  words  used  in  this  document such as "expects,"
"anticipates,"  "believes"  and  "may," as well as similar words and expressions
used  herein, identify and refer to statements describing events that may or may
not  occur  in  the future.  These forward-looking statements and the matters to
which  they  refer are subject to considerable uncertainty that may cause actual
results  to  be  materially different from those described herein.  For example,
while  the  Company believes that trends in sludge treatment are moving in favor
of the Company's technology, such trends may not continue or may never result in
increased  sales  or  profits  to  the  Company  because  of the availability of
competing  processes.  Additional information about these and other factors that
may  adversely  affect  these  forward-looking  statements  are contained in the
Company's reports and filings with the Securities and Exchange Commissions.  The
Company  assumes  no  obligation to update forward-looking statements to reflect
actual  results,  changes  in  assumptions or changes in other factors affecting
forward-looking  information  except  to  the  extent  required  by  applicable
securities  laws.

                                    -  30  -

<TABLE>
<CAPTION>

                                           N-VIRO INTERNATIONAL CORPORATION
                                        CONSOLIDATED STATEMENTS OF OPERATIONS


                                                  Three Months Ended Dec. 31          Twelve Months Ended Dec. 31
                                                      2004               2003              2004              2003
                                             -----------------------  -----------  --------------------  ------------
<S>                                          <C>                      <C>          <C>                   <C>
Revenues. . . . . . . . . . . . . . . . . .  $            1,152,034   $1,338,736   $         5,453,493   $ 5,401,048

Cost of revenues. . . . . . . . . . . . . .                 835,661      977,632             3,940,703     3,970,380
                                             -----------------------  -----------  --------------------  ------------

Gross Profit. . . . . . . . . . . . . . . .                 316,373      361,104             1,512,790     1,430,668

Operating expenses. . . . . . . . . . . . .                 273,245      536,468             1,628,108     2,253,012
                                             -----------------------  -----------  --------------------  ------------

Operating income (loss) . . . . . . . . . .                  43,128     (175,364)             (115,318)     (822,344)

Nonoperating income (expense) . . . . . . .                 (28,918)    (535,850)               43,504      (699,834)
                                             -----------------------  -----------  --------------------  ------------

Income (loss) before income taxes . . . . .                  14,210     (711,214)              (71,814)   (1,522,178)

Federal and state income taxes. . . . . . .                       -            -                     -             -
                                             -----------------------  -----------  --------------------  ------------

Net income (loss) . . . . . . . . . . . . .  $               14,210   $ (711,214)  $           (71,814)  $(1,522,178)
                                             =======================  ===========  ====================  ============


Basic and diluted income (loss) per share .  $                 0.00   $    (0.28)  $             (0.02)  $     (0.59)
                                             =======================  ===========  ====================  ============

Weighted average common shares outstanding.               3,266,769    2,583,136             3,079,216     2,578,871
                                             =======================  ===========  ====================  ============
</TABLE>






</TEXT>
</DOCUMENT>
